The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Adenosine receptors in regulation of dendritic cell differentiation and function
Open accessAbstract
Differentiation of functional dendritic cells (DCs) critically depends on the microenvironment. DCs differentiate in hypoxic tumor sites and inflamed or damaged tissue. Because local concentrations of adenosine reach high physiologically relevant levels in these conditions, we assessed the expression of adenosine receptors and the effect of their activation on differentiation of human monocytes and mouse peritoneal macrophages and hematopoietic progenitor cells (HPCs) into myeloid DCs. Stimulation of adenosine receptors skews DC differentiation toward a distinct cell population characterized by expression of both DC and monocyte/macrophage cell surface markers. Pharmacologic analysis and experiments with cells from A2B adenosine receptor knockout mice identified A2B receptor as the mediator of adenosine effects on DCs. Unlike normal myeloid DCs, adenosine-differentiated DCs have impaired allostimulatory activity and express high levels of angiogenic, pro-inflammatory, immune suppressor, and tolerogenic factors, including VEGF, IL-8, IL-6, IL-10, COX-2, TGF-β, and IDO. They promoted tumor growth if injected into tumors implanted in mice. Using adenosine desaminase knockout animals, we showed that DCs with proangiogenic phenotype are highly abundant under conditions associated with elevated levels of extracellular adenosine in vivo. Adenosine signaling through A2B receptor is an important factor of aberrant DC differentiation and generation of tolerogenic, angiogenic, and proinflammatory cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The engagement of adenosine 2A receptor (A2AR) with adenosine elicits immunoinhibitory effects: suppressing the activities of tumor-infiltrating CD8+ T cells and hampering the function and differentiation of DCs [333, 334].”
From Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,028
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 900
Zea, A. H., Rodrı́guez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. F., Quiceno, D. G., Youmans, A. J., O’Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 852
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Fredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430
Research works printed but not linked: 1
- Merrill, 1997, Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis., Arthritis Rheum, 40, 1308
Cited by
Sorted by citations
Items 401–441 of 441
Targeting CD73 for anti-tumor immunity
Liu, S., Laurent, P.-A., Deutsch, É., Meziani, L., & Mondini, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00016-3
Qin, D., Huang, K., Yao, Z., Xi, P., Jiang, L., Wei, R., & Li, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4829619/v1
Innate Immune Recognition of EBV
Stewart, J., & Damania, B. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_297
Adenosine in the Immune System
Haskó, G., Koscsó, B., & Csóka, B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_12
Vaccines in RCC: Clinical and Biological Relevance
Lowe, D. B., Finke, J. H., García, J. A., & Storkus, W. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_22
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755576
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755546
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755567
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755585
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755564
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755549
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26401828
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755591
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755588
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755561
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755579
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755570
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755552
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755582
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26402057
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755555
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755573
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755558
Liu, J., Li, H., Wang, L., Wang, S., & Tang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26755594
Rocha-Vieira, T. C., & Meyer-Fernandes, J. R. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130913
Akkineni, S., Pasupuleti, D., Gulani, M. A., Harsoda, Y., D’Souza, M. J., Chbib, C., & Uddin, M. N. (2026) · Vaccines · doi:10.3390/vaccines14030215
CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer
Eide, I. J. Z., Dyrbekk, A. P. H., Bisha, I., Haberichter, T., Lakis, S., Chan, J., Lewis, A. R., Martin, P., Cooper, Z. A., & Brustugun, O. T. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1755595
Immunomodulation de l'arthrite expérimentale par les cellules dendritiques tolérogènes.
Quentin, J. (2011) · theses.fr (ABES) · doi:10.70675/df771e9dzc254z4ad5za2c0z0fdf279aae87
Caractérisation et régulation des lymphocytes T CD4+CD73+ en contextes physiologique et pathologique
Bossennec, M. (2018) · theses.fr (ABES) · doi:10.70675/7ec104e7z6341z4faez8480z6c3f00a1039f
Le rôle de deux alarmines extracellulaires, HMGB1 et l’ATP, dans le cadre du cancer colorectal
Dillard, C. (2021) · theses.fr (ABES) · doi:10.70675/51029938z640az4398za0f8z6a69fb660b30
Tian, Y., Guo, J., Sun, J., Zhang, X., Zhou, G., Ye, L., Zhang, Y., Liu, P., Zhou, J., Xiao, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71323-0 · Cited by 1
Hernández-Ledesma, A. L., Coss-Navarrete, E. L., Salazar-Magaña, S., Ramírez-Espinosa, D., Tinajero-Nieto, L., Torres-Valdez, E., Peña-Ayala, A., Félix-Rodríguez, G., Frontana-Vázquez, G., García-Sotelo, J. S., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1771959
Gałȩzowski, M., Kujawa, M., Bobowska, A., Stefaniak-Szałas, M., Szeremeta‐Spisak, J., Nowogródzki, M., Ćwiertnia, G., Niedziejko, P., Radzimierski, A., Gluza, K., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00868
Nachtigall, J., Maurer, C. K., Lecomte, M., Schiemann, K., Zaynagetdinov, R., Reuter, T., & Scheible, H. (2026) · Xenobiotica · doi:10.1080/00498254.2026.2720770
Self-citationTalekar, S., Lade, V., & Ghosh, S. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2736246
Fan, J., Mao, Y., Liu, L., Ren, Z., Zhou, Z., Ma, Y., Lu, X., Cui, G., Zhang, X., & Zhou, X. (2026) · iScience · doi:10.1016/j.isci.2026.117695
BindingDB Entry 50012030: Adenosine A
BindingDB (2022) · UC San Diego · doi:10.7270/q2m330f6
Metadata
- Authors
- Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., & Dikov, M. M.
- Affiliations
- Division of Hematology/Oncology,
- Department of Medicine,
- Vanderbilt University (US)
- Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2008-09-01
- Volume
- 112
- Issue
- 5
- Pages
- 1822-1831
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2518889
- OpenAlex
- W1981552113
- Cited by
- 430
- References
- 44
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 28 · 2023: 40 · 2022: 33 · 2021: 33 · 2020: 43 · 2019: 23 · 2018: 24 · 2017: 27 · 2016: 17 · 2015: 13 · 2014: 24 · 2013: 18 · 2012: 18
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Histiocytosis Association
- Vanderbilt University
- Vanderbilt-Ingram Cancer Center (5P30-CA068485, CA100562, CA068485)
- National Institutes of Health (CA-068485)
- National Heart, Lung, and Blood Institute (R01HL070952, HL70952, R01HL076306, R01HL070073, HL76306)
- National Cancer Institute (R01CA100562, CA76321, R01CA076321, CA100562, P30CA068485)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- adenosine receptors, adenosine A2B receptor, dendritic cell differentiation, myeloid dendritic cells, adenosine signaling, monocytes, peritoneal macrophages, hematopoietic progenitor cells, tumor microenvironment, hypoxia, allostimulatory activity, angiogenic factors, immunosuppression, tumor growth, vascular endothelial growth factor, IDO, TGF-beta
- MeSH terms
- Adenosine, Adenosine Deaminase, Animals, Base Sequence, Cell Differentiation, Dendritic Cells, Humans, Immune Tolerance, Male, Mice, Inbred C57BL, Neoplasms, Experimental, Neovascularization, Pathologic, Signal Transduction, DNA Primers, Receptors, Purinergic P1, Mice, Knockout, Inflammation Mediators, Receptor, Adenosine A2B, Mice, Purinergic P1 Receptor Antagonists, Adenosine A2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
